H, Comparison by qRT-PCR of FACS-purified MaSC-enriched basal cells (MaSCs) from
the mammary gland and FACS-purified yMaSCs from yMaSC-derived organoids.
Purified LD cells were used as control. Data are normalized to Gapdh expression and are referred to MaSCs levels for basal genes and to LD levels for all the luminal markers (each set to 1).
I, Representative images of whole-mount hematoxylin staining of cleared fat pad with reconstituted mammary trees from transplanted yMaSCs (from wtYAP), native MaSCs (positive control) and rtTA/EGFP control LD cells (negative control). Scale bar, 0.5 cm. Figure 3J of Figure 1D ); tagged Flag-hYAP (with a higher molecular weight than endogenous mouse YAP) is induced. Lane 3: organoids from yMaSCs cultured in the absence of doxycycline (Flag-hYAP turned off, but endogenous YAP/TAZ remain expressed). Lane 4: control of endogenous MaSCs. GAPDH serves as loading control. 
J, This refers to

Bright-field and GFP-fluorescence movie showing a single pancreatic acinus derived from
Ptf1a-CreERTM; R26-LSL-rtTA-IRES-EGFP; tetO-YAP S127A mice during conversion into cyst-like organoid at the indicated time points (hours) after doxycycline addition.
EXTENDED EXPERIMENTAL PROCEDURES
Reagents, plasmids and transfections
Doxycycline hyclate, fibronectin, collagen I, heparin, insulin, dexamethasone, SBTI (Soybean Trypsin Inhibitor), gastrin, N-acethylcysteine, nicotinamide, T3 (Triiodo-L-Thyronine), tamoxifen and 4-OH-tamoxifen were from Sigma. Murine EGF, murine bFGF, human FGF10, human Noggin, human IGF, murine prolactin and BMP4 were from Peprotech. N2, B27
(always containing vitamin A), BPE and ITS-X (Insulin-Transferrin-Selenium-Ethanolamine) supplements were from Life Technologies. R-Spondin1 was from Sino Biological. Matrigel was from BD Biosciences (Corning). Rat tail collagen type I was from Cultrex.
GFP-and Cre-expressing adenoviruses were from University of Iowa, Gene Transfer Vector
Core. For inducible expression of YAP and TAZ, cDNA for siRNA-insensitive Flag-hYAP1
wt, S94A (TEAD-binding mutant (Zhao et al., 2008) ) and 5SA (LATS-mutant sites (Aragona et al., 2013) ) and for Flag-mTAZ4SA (Azzolin et al., 2012) were subcloned in FUW-tetO-MCS, obtained by substituting the Oct4 sequence in FUW-tetO-hOct4 (Addgene #20726 (Hockemeyer et al., 2008) ) with a new multiple cloning site (MCS). This generated the FUW-tetO-wtYAP, FUW-tetO-YAPS94A, FUW-tetO-YAP5SA, FUW-tetO-TAZ4SA used throughout this study. FUW-tetO-MCS (empty vector) or FUW-tetO-EGFP plasmids were used as controls, as previously indicated (Cordenonsi et al., 2011) .
For stable expression of GFP, we used pRRLSIN.cPPT.PGK-GFP.WPRE (gift of L. Naldini) lentiviral vector.
For Cre-excisable expression of rtTA, we used LV-CMV-rtTA-LoxP ( Figures S4L-N) , obtained by substituting the Cre cDNA in LV-CMV-Cre-LoxP with the cDNA of rtTA from FUdeltaGW-rtTA (Addgene #19780 (Maherali et al., 2008) ).
For Cre-excisable lentiviral vector containing the tetO-Flag-hYAP wt cassette, we used LVtetO-YAP wt-LoxP ( Figures S4L-N) , obtained by substituting the CMV-Cre cassette in LV-CMV-Cre-LoxP with the tetO-Flag-hYAP wt cassette from FUW-tetO-Flag-hYAP1 wt.
All constructs were confirmed by sequencing.
siRNA transfections were done with Lipofectamine RNAi-MAX (Life technologies) in antibiotics-free medium according to manufacturer instructions. Sequences of siRNAs targeting murine Yap and Taz were as previously decribed (Azzolin et al., 2014) .
DNA transfections were done with TransitLT1 (Mirus Bio) according to manufacturer instructions.
Lentiviral preparation
HEK293T cells (checked routinely for absence of mycoplasma contaminations) were kept in DMEM supplemented with 10% FBS (Life Technologies), Glutamine and Antibiotics (HEK medium). Lentiviral particles were prepared by transiently transfecting HEK293T
with lentiviral vectors (10 micrograms/10 cm dishes) together with packaging vectors pMD2-VSVG (2.5 micrograms) and pPAX2 (7.5 micrograms) by using TransIT-LT1
(Mirus Bio) according to manufacturer instructions. Specifically, 60 µl of TransIT-LT1 reagent was diluted in 1.5 ml of Opti-MEM (Life Technologies) for each 10 cm dish, incubated with the vector DNA 15 min at RT and gently distributed over to the cell medium (dish contained about 10 ml of HEK medium). After 8 hr, HEK medium was changed. 48 hr post-transfection supernatant was collected, filtered through 0.45 micrometers and directly stored at -20°C; we did not concentrate viral supernatants. We also seldom measured the lentiviral titer of various supernatants used in our experiments using the QuickTiter Lentivirus Titer kit (lentivirus-associated HIV p24; Cell Biolabs)
according to the manufacturer's protocol. As reference, viral supernatants were in the range 16 -20 ng of p24/ml. This titer corresponds to a viral particle concentration of about 2x10 8 particles/ml. As determined by PCR of integrated lentiviral DNA of HEK293T transduced with pRRL-EGFP, this roughly corresponds to 2x10 6 transduction units (TU)/ml in the unconcentrated viral supernatant stock.
Lentiviral Infection of primary cells
As example, for a typical infection of a 3 cm dish containing primary cells, we used 500 µl of each unconcentrated viral supernatant diluted to 1x cell-specific medium in 2 ml final volume. For mammary gland cells, we mixed one volume (e.g., 500 µl/3.5 cm dish)
of FUdeltaGW-rtTA supernatant, one volume of the FUW-tetO-YAP (or TAZ) supernatant, and added two volumes of serum-free MG medium with 2X concentrations of supplements. For neurons, for a 3.5 cm well, we mixed 500 µl of FUdeltaGW-rtTA with 250 µl of FUW-tetO-wtYAP (or negative controls) viral supernatants, 250 µl of HEK medium with 1.5 ml of serum-free Neurobasal medium with 2X B27.
Mammary gland dissociation
Primary MECs were isolated from the mammary glands of 8-to 12-week-old virgin C57BL/6J mice (unless otherwise specified), according to standard procedures (Stingl et 
Matrigel culture of mammary colonies and organoids
After infection in 2D cultures and induction with doxycycline for 7 days, mammary cells were detached with trypsin and seeded at a density of 1,000 cells/well in 24-well ultralow attachment plates (Corning) in mammary colony medium (DMEM/F12 containing glutamine, antibiotics, 5% Matrigel, 5% FBS, 10 ng/ml murine EGF, 20 ng/ml murine bFGF, and 4 µg/ml heparin) containing doxycycline (2 µg/ml). Primary colonies were counted 14 days after seeding. To show the self-renewal capacity of yMaSCs independently of exogenous YAP/TAZ supply (i.e, independently of doxycycline administration), primary colonies were recovered from the MG-colony medium by collecting the samples and incubation with an excess volume of ice cold HBSS in order to solubilize Matrigel. After 1 hour, colonies were rinsed 3 times in cold HBSS by centrifugation at 1000 rpm for 5 min and incubated in trypsin 0.05% for 30 min to obtain a single cell suspension. Cells were counted and re-seeded at 1,000 cells/well in 24-well ultralow attachment plates in MG colony medium without doxycycline for further passaging.
For mammary organoid formation, primary colonies were recovered from MG colony medium in cold HBSS and transferred in 100% Matrigel. After Matrigel formed a gel at 37°C, MG organoid medium was added (Advanced DMEM/F12 supplemented with Hepes, GlutaMax, antibiotics, B27 1X, 50 ng/ml murine EGF, 20 ng/ml murine bFGF, 4 µg/ml heparin, 100 ng/ml Noggin and 1 µg/ml R-Spondin1). Note that at this step we do not dissociate at single cell level the primary colonies but simply transfer them to organoid culture conditions. After few days, colonies started to form budding organoids. 64-75%
(depending on the experiment) of yMaSC colonies evolved as organoids and were maintained and passaged without doxycycline. Also note that direct plating of MaSCs, LD control EGFPinfected, as well as YAP-infected cells, directly into organoid culture conditions did not result in any outgrowth, indicating that the intermediate step in colony culture conditions is required for organoid development. 2 weeks after seeding, organoids were removed from Matrigel, trypsin-dissociated and transferred to fresh Matrigel. Passages were performed in a 1:4-1:8 split ratio every 2 weeks. For analysis, colonies and organoids were recovered from Matrigel as before, and either embedded in OCT medium (PolyFreeze, Sigma) to obtain frozen sections for immunofluorescence or processed for protein or RNA extraction.
For the experiment depicted in Figure S1F , cells were plated into 96-well plate as single cells visually verified and their colony forming capacity was monitored. Based on the fluorescence of EGFP-positive LD cells (negative control cells), we measured that our rate of infection is about 50%.
For α-and β-casein induction ( Figures 3F and S3G ), Matrigel-embeded organoids derived from yMaSCs or MaSCs were treated with MG organoid medium supplemented with insulin (10 µg/ml) and dexamethasone (1 µg/ml) in the absence or presence of lactogenic hormone prolactin (5 µg/ml) for 7 days. Organoids were then recovered from Matrigel as before and processed for RNA extraction. Cell aliquots or organoids resuspended in 10 µl PBS/10% Matrigel were injected into the inguinal mammary fat pads of NOD-SCID mice (Charles River), which had been cleared of endogenous mammary epithelium at 3 weeks of age. Animals were then administered doxycycline in the drinking water for 2 weeks and then maintained without doxycycline for additional 8-10 weeks. Transplanted mammary fat pads were examined for gland reconstitution by whole-mount staining, GFP native fluorescence and immunofluorescence on sections from paraffin-embedded biopsies. Only the presence of GFP-positive branched ductal trees with lobules and/or terminal end buds was scored as positive reconstitution. For wholemount analysis of mammary glands, freshly-explanted glands were fixed in PFA 4% (2 hours) and ethanol 70% (overnight). Glands were rehydrated, stained overnight with hematoxylin, subsequently dehydrated in graded ethanols, cleared by incubation in benzyl-alcohol/benzyl benzoate (1:2; Sigma) and imaged.
Cleared Mammary Fat Pad Transplantation
Lineage tracing of neurons to yNSCs conversion
For the experiment depicted in Figures 4C-F and S4F, J, we obtained cortical neurons from
Syn1-Cre; R26-CAG-LSL-tdTomato/+ embryos (day 1 and 2 as described in experimental procedures). When indicated, these cells were transduced as described in experimental procedures (day 3). Cells were then treated with AraC/B27 containing medium as before and, after 7 days, switched to doxycycline containing-NSC medium to activate YAP expression and induce yNSC formation from tdTomato-positive neurons. Syn1-Cre; R26-CAG-LSLtdTomato/+ neurons transduced with FUdeltaGW-rtTA in combination with FUW-tetO-EGFP or FUW-tetO-YAPS94A never gave rise to any neurospheres and died after few days after transfer to NSC medium. Each embryo genotype was confirmed on tail biopsies postbrain dissociation; as separate negative controls, neurons derived from R26-CAG-LSLtdTomato/+ littermates (Syn1-Cre negative) were transduced with FUW-tetO-wtYAP and FUdeltaGW-rtTA viral supernatants, and never gave rise to tdTomato-positive yNSCs. These same neurons transduced with FUdeltaGW-rtTA in combination with FUW-tetO-EGFP or FUW-tetO-YAPS94A never gave rise to any neurospheres.
For the experiment depicted in Figure 4G , we obtained hippocampal neurons from Thy1-Cre;
R26-LSL-LacZ/+ embryos (day 1 and 2 as described in experimental procedures). These cells were transduced as described in experimental procedures (day 3). Cells were then treated with AraC/B27 containing medium as before and, after 7 days, switched to doxycycline were treated as all the others, and never gave rise yNSCs.
For the experiment with excisable YAP vectors ( Figures S4L-N) , neurons were transduced (day 3) for 24 hours with LV-tetO-wtYAP-LoxP in combination with LV-CMV-rtTA-LoxP.
Neurons were then treated with AraC/B27 containing medium as before and, after 7 days, switched to doxycycline containing-NSC medium to activate YAP expression.
Primary neural stem cells (NSCs) isolation and culture
Neural stem cells (NSCs) were isolated as previously reported (Ray and Gage, 2006 ) from the telencephalon of C57BL/6J E18 embryos or from mice of the indicated genotype.
Telencephalons were minced and digested in trypsin 0.05% for 10 min at 37°C. The cell suspension was treated with DNaseI (Roche) and washed. NSCs were cultured in DMEM/F12
supplemented with 1% N2, 20 ng/ml murine EGF, 20 ng/ml murine bFGF, glutamine and antibiotics. For passages, neurospheres were dissociated into single cells with TrypLE
Express (Life Technologies).
NSCs/yNSCs transfection, infection and differentiation
Prior to transfection with siRNA, yNSCs were plated on fibronectin coated-plate in NSC medium, to allow a 2D culture; the next day, cells were transfected with siRNA and after 24
hours, replated in ultra-low attachment plates to allow neurosphere formation. Neurospheres were counted after 7 days from plating. For neuronal differentiation (Choi et al., 2014) , NSCs or yNSCs were cultured over a thin Matrigel layer. Differentiation medium was Neurobasal supplemented with 1X B27, glutamine.
For astrocyte differentiation (Bonaguidi et al., 2005) , NSCs or yNSCs were plated on fibronectin coated-plate in NSC medium, to allow a 2D culture. The next day, medium was changed to DMEM (Life Technologies) containing 25 ng/ml LIF, 25 ng/ml BMP4, glutamine, and antibiotics for 2 weeks.
For oligodendrocyte differentiation (Hsieh et al., 2004) , NSCs or yNSCs were plated on fibronectin coated-plate in NSC medium, to allow a 2D culture. The next day, medium was changed to Neurobasal (Life Technologies) containing 1x B27, 500 ng/ml IGF, 30 ng/ml T3, glutamine, and antibiotics for 2 weeks.
NSCs transplantation
P0 CD1 mice pups were used for cell transplantations. Pups were anesthetized by hypothermia (3 minutes) and fixed on ice-cold block during cell injection. Cells were resuspended in ice-cold HBSS (5x10 4 cells/µl) and injected into both hemispheres of neonatal mice with a 5µl-volume Hamilton syringe (2µl/injection). One month after the procedures, the grafted animals were perfused with PBS and 4%PFA, and the brains were excised and processed for immunofluorescence.
Lineage tracing of pancreatic exocrine acinar cells
For the experiment depicted in Figures 6E-F (see also scheme in Figure S6I ), we obtained acinar explants from 6 week-old Ptf1a-CreERTM; R26-LSL-rtTA-IRES-EGFP/+; tetO-YAP S127A mice (Pan et al., 2013) . Mice with this genotype were given tamoxifen by three daily i.p. injections of a 10 mg/ml solution in corn oil. 1 week after the last tamoxifen injection, mice were sacrificed and pancreas was dissociated to obtain rtTA-IRES-EGFP + -labeled exocrine acinar cells. Primary pancreatic acinar cells were isolated and cultured as described in experimental procedures. For induction of pancreatic organoids, acinar explants were treated with 2 µg/ml doxycycline.
Matrigel culture of yDucts organoids
To show the self-renewal capacity of pancreatic organoids independently of exogenous YAP supply (i.e, independently of doxycycline administration), organoids were recovered from Matrigel or collagen cultures, trypsinized to obtain a single cell suspension and re-seeded in 100% Matrigel covered with pancreatic organoid medium. For analysis, organoids were recovered from Matrigel as before and processed for immunofluorescence or for protein or RNA extraction.
For the differentiation experiments shown in Figure S6R , yDucts were removed from Matrigel, trypsin-dissociated and seeded as single cells in Matrigel-coated (1:50) chamber slides. Cells were expanded in DMEM supplemented with 0.5% BSA, 1% ITS-X and 1x N2
and 50 ng/ml EGF and antibiotics for 5 days. For differentiation, cells were switched to DMEM/F12 supplemented with 1% ITS-X, 10 ng/ml bFGF, 10 mM nicotinamide, 50 ng/ml Exendin-4 and 10 ng/ml BMP4 and antibiotics for further 8 days. Cells were fixed in 4% PFA at Day 0 or Day 8 of differentiation and processed for immunofluorescence.
Culture of pancreatic ductal organoids (Ducts)
For culture of pancreatic duct-derived organoids, pancreatic ducts were isolated from the bulk of the pancreas as previously described (Huch et al., 2013) with minor modifications. The whole pancreas of 6-to 9-week-old mice of the indicated genotypes was grossly minced and digested by collagenase/dispase dissociation: DMEM medium (Life Technologies)
supplemented with collagenase type XI 0.012% (w/v) (Sigma), dispase 0.012% (w/v) (Life Technologies), 1% FBS (Life Technologies) and antibiotics at 37°C for 1 hour. Isolated pancreatic duct fragments were hand-picked under a dissecting microscope, carefully washed in DMEM medium and embedded in 100% Matrigel. After Matrigel formed a gel, pancreatic organoid medium (Advanced DMEM/F12 supplemented with 1x B27, 1.25mM NAcetylcysteine, 10 nM gastrin, 50 ng/ml murine EGF, 100 ng/ml human Noggin, 100 ng/ml human FGF10, 10 mM Nicotinamide, 1 µg/ml R-Spondin1 and antibiotics) was added. Ductal fragments rapidly expanded to form cyst-like organoids within 5 days. Organoids were removed from Matrigel by incubation in ice cold HBSS, dissociated with trypsin 0.05% for 30
min to obtain a single cells suspension and reseeded in 100% fresh Matrigel. Organoid cultures were maintained for at least 9 months passaging every 10 days. For analysis, organoids were recovered from Matrigel and processed for immunofluorescence or for protein or RNA extraction.
For the experiments depicted in Figure S6C , pancreatic duct fragments were isolated from 9 with the following Taqman Gene Expression Assays: 18S (Hs99999901_s1),
(Mm00432359_m1). Expression levels were normalized to 18S-rRNA for each sample.
Immunofluorescence and microscopy
Immunofluorescences on PFA-fixed samples were performed as previously described (Cordenonsi et al., 2011) . Briefly, samples were fixed 10 min at room temperature with 4% PFA solution. Slides were permeabilized 10 min at RT with PBS 0.3% Triton X-100, and processed for immunofluorescence using the following conditions: blocking in 10% Goat Serum (GS) in PBS 0.1% Triton X-100 (PBST) for 1 hr followed by incubation with primary antibodies (diluted in 2% GS in PBST) overnight at 4°C, four washes in PBST and incubation with secondary antibodies (1:200 in 2% GS in PBST) for 2 hours at room temperature.
Samples were counterstained with ProLong-DAPI (Molecular Probes, Life Technologies) to label cell nuclei.
For immunofluorescence on mammary colonies and organoids (Figures 2B-C, 3B-E, S2, S3C-F), outgrowths freshly recovered from Matrigel were embedded in OCT tissue-freezing medium (PolyFreeze, Sigma) and frozen on dry ice. 8 µm cryostat sections for all types of organoids were cut at -20 °C. Sections were mounted on glass slides and dried for at least 30 min. The sections were then fixed with 4% formaldehyde for 10 min. After washing with PBS the sections were processed as described above. For immunofluorescence on pancreatic organoids or acini ( Figures 6H and S6A , E), pancreatic acini and organoids were fixed overnight in PBS 4% PFA at 4°C, permeabilized with two washes in PBS 0.5% NP40 for 20 minutes at 4°C, followed by one wash in PBS 0.3% Triton X-100 for 20 minutes at room temperature. After two washes in PBS 0.1% Triton X-100 (PBST) for 15 minutes at room temperature, acini or organoids were blocked with two washes in PBST 10% GS for 1 hour at room temperature, and incubated overnight with primary antibodies. The following day, cells were washed twice in PBST 2% GS for 15 minutes at 4°C, and five more times in PBT 2%
GS for 1 hour at 4°C. Secondary antibodies were incubated overnight. The third day, cells were washed five times in PBST for 15 minutes, incubated 20 min with DAPI solution and mounted in glycerol.
For immunofluorescence on mammary and brain tissue, biopsies were fixed with PFA, paraffin-embedded and cut in 10 µm-thick sections. Sections were re-hydrated and antigen retrieval was performed by incubation in citrate buffer 0.01 M pH 6 at 95°C for 20 minutes.
Slides were then permeabilized (10 min at RT with PBS 0.3% Triton X-100 for mammary sections and 10 min at RT with PBS 1% Triton X-100 for brain sections) and processed as described above.
Primary 
Western blot
Western blots were carried out as described in Ref. (Cordenonsi et al., 2011) . Anti-YAP/TAZ (63.7; sc-101199) and anti-p63 (4A4; sc-8431) monoclonal antibodies were from Santa Cruz.
anti-GAPDH (MAB347) monoclonal antibody was from Millipore. Anti-K14 (Ab7800) mouse monoclonal antibody and anti-K8 (Ab14053) chicken polyclonal antibody were from
Abcam.
Quantitative Real-Time PCR (qRT-PCR)
Cells or tissues were harvested in TriPure (Roche) for total RNA extraction, and contaminant DNA was removed by DNase treatment. qRT-PCR analyses were carried out on retrotranscribed cDNAs with Rotor-Gene Q (Qiagen) thermal cycler and analyzed with Rotor- 
Microarray experiments
For microarray experiments, Mouse Genome 430 2.0 arrays (Affymetrix, Santa Clara, CA, USA) were used. Total RNA was extracted using TriPure (Roche) from: 1) luminal differentiated mammary cells (3 replicates), organoids derived from yMaSCs (3 replicates), and MaSCs (3 replicates);
2) cortical neurons (3 replicates), yNSCs (from YAP wild type-transduced cortical neurons, passage 2; 3 replicates), and native NSCs (3 replicates);
3) pancreatic exocrine acini (4 replicates), yDucts (passage 10; 4 replicates), and Ducts (passage 10; 4 replicates).
RNA quality and purity were assessed on the Agilent Bioanalyzer 2100 (Agilent Technologies, Waldbronn, Germany); RNA concentration was determined using the NanoDrop ND-1000 Spectrophotometer (NanoDrop Technologies Inc.). RNA was then treated with DNaseI (Ambion). In vitro transcription, hybridization and biotin labeling were performed according to Affymetrix 3'IVT protocol (Affymetrix). As control of effective gene modulation and of the whole procedure, we monitored the expression levels of tissue-specific markers of differentiated cells or stem/progenitors by qRT-PCR prior to microarray hybridization and in the final microarray data.
All data analyses were performed in R (version 3.1.2) using Bioconductor libraries (BioC 3.0) and R statistical packages. Probe level signals were converted to log2 expression values using robust multi-array average procedure RMA (Irizarry et al., 2003) of Bioconductor affy package. Raw data are available at Gene Expression Omnibus under accession number GSE70174.
Global unsupervised clustering was performed using the function hclust of R stats package with Pearson correlation as distance metric and average agglomeration method. Gene expression heatmaps have been generated using the function heatmap.2 of R gplots package after row-wise standardization of the expression values. Before unsupervised clustering, to reduce the effect of noise from non-varying genes, we removed those probe sets with a coefficient of variation smaller than the 90 th percentile of the coefficients of variation in the entire dataset. The filter retained 4511 probe sets that are more variable across samples in any of the 3 subsets (i.e., mammary, neuron, and pancreatic).
Differentially expressed genes were identified using Significance Analysis of Microarray algorithm coded in the samr R package (as in Ref. (Tusher et al., 2001) ). To identify differentially expressed genes, we selected those probe sets with an FDR ≤ 1%.
GO terms associated to genes coherently upregulated to Ducts and yDucts in comparison with acinar cells included RNA processing, positive regulation of cell cycle and control of cell death.
Mice
C57BL/6J mice and NOD-SCID mice were purchased from Charles River. Transgenic lines used in the experiments were gently provided by: Duojia Pan (Zhang et al., 2010 ) (Yap1 fl/fl and Pierre Chambon (K14-CreERT2) (Li et al., 2000) ; Doron Merckler (Thy1.2-Cre) (Dewachter et al., 2002) ; Ivan De Curtis and Riccardo Brambilla (Syn1-Cre) (Zhu et al., 2001) ; Giorgio Carmignoto (R26-CAG-LSL-tdTomato) (Madisen et al., 2010) ; Fernando Camargo (tetO-YAP S127A ) (Camargo et al., 2007) . Taz fl/fl and double Yap fl/fl ; Taz fl/fl conditional knock-out mice were as described in Ref. (Azzolin et al., 2014) . Ptf1a-CreERTM (stock #019378), R26-LSLrtTA-IRES-EGFP (stock #005670) and R26-rtTAM2 mice (stock #006965) were purchased from The Jackson Laboratory. Animals were genotyped with standard procedures (Morsut et al., 2010) and with the recommended set of primers. Animal experiments were performed adhering to our institutional guidelines as approved by OPBA and authorized by the Ministry of Health. To obtain Syn1-Cre lineage tracing studies, we used Syn1-Cre hemizygous females (as transgene expression in male mice results in germline recombination (Rempe et al., 2006) ) with R26-LSL-rtTA-IRES-EGFP or with R26-CAG-LSL-tdTomato homozygous males.
Littermate embryos derived from these crossings were harvested at E18-19 and kept separate for neurons derivation; genotypes were confirmed on embryonic tail biopsies.
To obtain R26-rtTAM2/+ ; tetO-YAP S127A mice, we crossed R26-rtTAM2/+ mice with tetO-YAP S127A mice. R26-rtTAM2/+ littermates were used as negative control.
To obtain Ptf1a-CreERTM; R26-LSL-rtTA-IRES-EGFP/+; tetO-YAP S127A mice, we crossed
Ptf1a-CreERTM; R26-LSL-rtTA-IRES-EGFP/LSL-rtTA-IRES-EGFP mice with tetO-YAP
S127A
mice. Ptf1a-CreERTM; R26-LSL-rtTA-IRES-EGFP/+ littermates were used as negative control.
